Arkolith/Insider Trading/TAK

TAK Insider Trading

Takeda Pharmaceutical Co Ltd · full profile →Last filing Sep 2, 2026
Net Selling · 180d
Open-Market Buys (180d)
$0
0 insiders
Open-Market Sells (180d)
$12.4M
13 insiders
Net Insider Flow
-$12.4M
open market, 180d
Reporting Insiders
13
19 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp

Recent Form 4 Transactions

80 shown
DateInsiderRoleActionSharesPriceValue
Sep 2, 2026Plump Andrew StewartPresident, R&D, DirectorSell(S)116K$18.49$2.1M
Aug 19, 2026Plump Andrew StewartPresident, R&D, DirectorSell(S)20K$18.49$363K
Aug 18, 2026Greenway Nicola Deidre PetalChief Human Resources OfficerSell(S)13K$18.11$235K
Aug 11, 2026Shannon Elaine MaryPres., Global Supply & QualitySell(S)20K$17.55$357K
Aug 10, 2026Greenway Nicola Deidre PetalChief Human Resources OfficerSell(S)34K$17.51$589K
Aug 10, 2026Greenway Nicola Deidre PetalChief Human Resources OfficerSell(S)975$17.50$17K
Aug 10, 2026Plump Andrew StewartPresident, R&D, DirectorSell(S)165K$17.10$2.8M
Aug 10, 2026Duprey Lauren RusckowskiChief Transformation OfficerSell(S)48K$17.10$814K
Aug 10, 2026Pacheco Rhonda JanicePresident, U.S. Business UnitSell(S)17K$17.10$289K
Aug 10, 2026Ibrahim Ramy Riad AhmedPresident, PDT BUSell(S)7K$17.10$124K
Aug 10, 2026Farajallah Awny Samaan BotrosChief Medical OfficerSell(S)14K$17.10$240K
Aug 10, 2026Shannon Elaine MaryPres., Global Supply & QualitySell(S)4K$17.10$68K
Aug 10, 2026Bitetti Teresa MariePresident, OBUSell(S)50K$17.10$855K
Aug 10, 2026Pignagnoli Agosti MarcelloHead, Strat. & Port. DevSell(S)23K$17.10$393K
Aug 10, 2026Ricci GabrieleChief Data & Tech. OfficerSell(S)25K$17.10$429K
Aug 10, 2026Furney Natalie Anne MarieGlobal General CounselSell(S)31K$17.10$528K
Aug 10, 2026Platford Giles RichardPresident, IBUSell(S)31K$17.10$532K
Aug 10, 2026Kim Julie So-YoungPresident and CEO, DirectorSell(S)89K$17.10$1.5M
Aug 10, 2026Greenway Nicola Deidre PetalChief Human Resources OfficerSell(S)7K$17.10$116K
Jul 1, 2026Platford Giles RichardPresident, IBUGrant(A)50K—$0
Jul 1, 2026Miyabashira AsukaPresident, Japan Pharma B.U.Grant(A)2K—$0
Jul 1, 2026Miyabashira AsukaPresident, Japan Pharma B.U.Grant(A)664—$0
Jul 1, 2026Miyabashira AsukaPresident, Japan Pharma B.U.Grant(A)664—$0
Jul 1, 2026Miyabashira AsukaPresident, Japan Pharma B.U.Grant(A)666—$0
Jul 1, 2026Furuta MilanoChief Financial Officer, DirectorGrant(A)12K—$0
Jul 1, 2026Ibrahim Ramy Riad AhmedPresident, PDT BUGrant(A)25K—$0
Jul 1, 2026Farajallah Awny Samaan BotrosChief Medical OfficerGrant(A)18K—$0
Jul 1, 2026Furney Natalie Anne MarieGlobal General CounselGrant(A)44K—$0
Jul 1, 2026Ricci GabrieleChief Data & Tech. OfficerGrant(A)38K—$0
Jul 1, 2026Shannon Elaine MaryPres., Global Supply & QualityGrant(A)30K—$0
Jul 1, 2026Kim Julie So-YoungPresident and CEO, DirectorGrant(A)50K—$0
Jul 1, 2026Kim Julie So-YoungPresident and CEO, DirectorGrant(A)23K—$0
Jul 1, 2026Kim Julie So-YoungPresident and CEO, DirectorGrant(A)8K—$0
Jul 1, 2026Kim Julie So-YoungPresident and CEO, DirectorGrant(A)8K—$0
Jul 1, 2026Kim Julie So-YoungPresident and CEO, DirectorGrant(A)8K—$0
Jul 1, 2026Plump Andrew StewartPresident, R&D, DirectorGrant(A)125K—$0
Jul 1, 2026Smoter Jennifer MarieChief Comm. & Gov. OfficerGrant(A)19K—$0
Jul 1, 2026Broussard Bruce DDirectorGrant(A)4K—$0
Jul 1, 2026Broussard Bruce DDirectorGrant(A)1K—$0
Jul 1, 2026Stoffels PaulusDirectorGrant(A)4K—$0
Jul 1, 2026Stoffels PaulusDirectorGrant(A)1K—$0
Jul 1, 2026Furuta MilanoChief Financial Officer, DirectorGrant(A)4K—$0
Jul 1, 2026Furuta MilanoChief Financial Officer, DirectorGrant(A)4K—$0
Jul 1, 2026Furuta MilanoChief Financial Officer, DirectorGrant(A)4K—$0
Jul 1, 2026Greenway Nicola Deidre PetalChief Human Resources OfficerGrant(A)23K—$0
Jul 1, 2026Pacheco Rhonda JanicePresident, U.S. Business UnitGrant(A)50K—$0
Jul 1, 2026Duprey Lauren RusckowskiChief Transformation OfficerGrant(A)45K—$0
Jul 1, 2026Bitetti Teresa MariePresident, OBUGrant(A)44K—$0
Jul 1, 2026Pignagnoli Agosti MarcelloHead, Strat. & Port. Dev.Grant(A)28K—$0
Jul 1, 2026Iijima MasamiDirectorGrant(A)2K—$0
Jul 1, 2026Gillis StevenDirectorGrant(A)4K—$0
Jul 1, 2026Gillis StevenDirectorGrant(A)1K—$0
Jul 1, 2026Kimura KoichiroDirectorGrant(A)2K—$0
Jul 1, 2026Kimura KoichiroDirectorGrant(A)2K—$0
Jul 1, 2026Iijima MasamiDirectorGrant(A)2K—$0
Jul 1, 2026Iijima MasamiDirectorDisposed to issuer(D)2K$4,931.20as filed—
Jul 1, 2026Tsusaka MikiDirectorGrant(A)2K—$0
Jul 1, 2026Tsusaka MikiDirectorGrant(A)2K—$0
Jul 1, 2026Maraganore JohnDirectorGrant(A)4K—$0
Jul 1, 2026Maraganore JohnDirectorGrant(A)1K—$0
Jul 1, 2026Reed Kimberly A.DirectorGrant(A)4K—$0
Jul 1, 2026Reed Kimberly A.DirectorGrant(A)1K—$0
Jul 1, 2026Miyabashira AsukaPresident, Japan Pharma B.U.Disposed to issuer(D)1K$4,931.40as filed—
Jul 1, 2026Furuta MilanoChief Financial Officer, DirectorDisposed to issuer(D)17K$4,931.50as filed—
Jul 1, 2026Tsusaka MikiDirectorDisposed to issuer(D)2K$4,931.20as filed—
Jul 1, 2026Gillis StevenDirectorDisposed to issuer(D)1K$4,931.20as filed—
Jul 1, 2026Maraganore JohnDirectorDisposed to issuer(D)1K$4,931.20as filed—
Jul 1, 2026Reed Kimberly A.DirectorDisposed to issuer(D)1K$4,931.20as filed—
Apr 27, 2026Furuta MilanoChief Financial Officer, DirectorGrant(A)8K—$0
Apr 27, 2026Bitetti Teresa MariePresident, OBUGrant(A)65K—$0
Apr 27, 2026Duprey Lauren RusckowskiChief Transformation OfficerGrant(A)60K—$0
Apr 27, 2026Furuta MilanoChief Financial Officer, DirectorGrant(A)8K—$0
Apr 27, 2026Kim Julie So-YoungCEO - ElectGrant(A)105K—$0
Apr 27, 2026Ricci GabrieleChief Data & Tech. OfficerGrant(A)35K—$0
Apr 27, 2026Pignagnoli Agosti MarcelloHead, Strat. & Port. Dev.Grant(A)28K—$0
Apr 27, 2026Platford Giles RichardPresident, IBUGrant(A)72K—$0
Apr 27, 2026Plump Andrew StewartPresident, R&D, DirectorGrant(A)212K—$0
Apr 27, 2026Weber Christophe PierrePresident and CEO, DirectorGrant(A)79K—$0
Apr 27, 2026Weber Christophe PierrePresident and CEO, DirectorGrant(A)165K—$0
Apr 27, 2026Weber Christophe PierrePresident and CEO, DirectorGrant(A)79K—$0

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Issuer: Takeda Pharmaceutical Co Ltd, SEC CIK 0001395064. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under TAK and shows every filing by that issuer.

Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-12. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).

Keep exploring

Connected pages for TAK